- Filed
- Dec 18, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted restated | Q3 2022 · Sep 30, 2022 | 13.52K sh |
| Shares Diluted | Q3 2022 · Sep 30, 2021 | 13.52K sh |
| Shares Diluted | Q3 2022 · Sep 30, 2021 | 13.52K sh |
| Shares Outstanding | Q3 2022 · Sep 30, 2022 | 13.52M sh |
| Short Term Investments | Q3 2022 · Sep 30, 2022 | $4M |
| Short Term Investments | Q3 2022 · Dec 31, 2021 | $2.5M |
| Cash And Equivalents | Q3 2022 · Sep 30, 2022 | $20.09M |
| Cash And Equivalents | Q3 2022 · Dec 31, 2021 | $23.47M |
| Stockholders Equity | Q3 2022 · Sep 30, 2022 | $36.23M |
| Stockholders Equity | Q3 2022 · Jun 30, 2022 | $37.16M |
| Stockholders Equity | Q3 2022 · Mar 31, 2022 | $37.44M |
| Stockholders Equity | Q3 2022 · Dec 31, 2021 | $36.37M |
| Stockholders Equity | Q3 2022 · Sep 30, 2021 | $36.24M |
| Stockholders Equity | Q3 2022 · Jun 30, 2021 | $34.72M |
| Stockholders Equity | Q3 2022 · Mar 31, 2021 | $34.08M |
| Stockholders Equity | Q3 2022 · Dec 31, 2020 | $33.78M |
| Total Liabilities | Q3 2022 · Sep 30, 2022 | $4.38M |
| Total Liabilities | Q3 2022 · Dec 31, 2021 | $3.35M |
| Total Assets | Q3 2022 · Sep 30, 2022 | $40.61M |
| Total Assets | Q3 2022 · Dec 31, 2021 | $39.72M |
| Eps Diluted | Q3 2022 · Sep 30, 2022 | −$0.07 |
| Eps Diluted | Q3 2022 · Sep 30, 2021 | $0.11 |
| Eps Diluted | Q3 2022 · Sep 30, 2021 | $0.18 |
| Sga Expense | Q3 2022 · Sep 30, 2022 | $31K |
| Sga Expense | Q3 2022 · Sep 30, 2022 | $92K |
| Sga Expense | Q3 2022 · Sep 30, 2021 | $33K |
| Sga Expense | Q3 2022 · Sep 30, 2021 | $89K |
| Net Income | Q3 2022 · Sep 30, 2022 | −$925K |
| Net Income | Q3 2022 · Sep 30, 2021 | $1.52M |
| Net Income | Q3 2022 · Sep 30, 2021 | $2.47M |
| Operating Cash Flow | Q3 2022 · Sep 30, 2021 | $23.01M |